Pt(IV)-PROTAC Complexes with Synergistic Antitumor Activity and Enhanced Membrane Permeability

被引：0
|
作者：
Li, Cheng-xin [1 ,2 ]
Zou, Zhi-ru [1 ,2 ]
Xu, Shan [1 ,2 ]
Shi, Jia-hui [1 ,2 ]
Zou, Yong [1 ,2 ]
Yan, Ming [1 ,2 ]
Zhang, Xue-jing [1 ,2 ]
机构：
[1] Sun Yat Sen Univ, State Key Lab Antiinfect Drug Discovery & Dev, Guangzhou 510006, Peoples R China
[2] Sun Yat Sen Univ, Sch Pharmaceut Sci, Guangdong Prov Key Lab Chiral Mol & Drug Discovery, Guangzhou 510006, Peoples R China
来源：
JOURNAL OF MEDICINAL CHEMISTRY | 2025年
关键词：
NUCLEOTIDE EXCISION-REPAIR; ANTICANCER ACTIVITY; PLATINUM DRUGS; CANCER; DELIVERY; FLUDARABINE; INHIBITOR; PRODRUGS; PARP1;
D O I：
10.1021/acs.jmedchem.4c02909
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
A class of Pt(IV)-PROTAC complexes was designed and synthesized with dual aims of inducing DNA strand damage and inhibiting DNA repair. These complexes showed good antiproliferative activity against a range of cancer cell lines. Enhanced intracellular uptake of platinum and PROTAC was observed. Multiple mechanisms of action were identified, including the induction of DNA damage, disruption of DNA repair, and activation of mitochondrial-dependent apoptosis. One of the Pt(IV)-PROTACs, CW-2, showed excellent antitumor activity in a xenograft mouse model. These results suggest that Pt(IV)-PROTAC represents a promising strategy for the development of novel antitumor therapeutics.
引用
收藏
页数：18
相关论文
共 50 条
  • [21] Pt(IV) Prodrug as a Potential Antitumor Agent with APE1 Inhibitory Activity
    Yuan, Yi
    Fu, Dingqiang
    Xu, Yan
    Wang, Xuyang
    Deng, Xiongfei
    Zhou, Shan
    Du, Feng
    Cui, Xin
    Deng, Yun
    Tang, Zhuo
    JOURNAL OF MEDICINAL CHEMISTRY, 2022, : 15344 - 15357
  • [22] PRECLINICAL ANTITUMOR-ACTIVITY OF ORALLY-ADMINISTERED PLATINUM(IV) COMPLEXES
    ROSE, WC
    CROSSWELL, AR
    SCHURIG, JE
    CASAZZA, AM
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1993, 32 (03) : 197 - 203
  • [23] Synthesis, characterization of diorganotin(IV) Schiff base complexes and their in vitro antitumor activity
    Yin, DD
    Jiang, YL
    Shan, L
    CHINESE JOURNAL OF CHEMISTRY, 2001, 19 (11) : 1136 - 1140
  • [24] Pt(IV) Complexes in the Search for Novel Platinum Prodrugs with Promising Activity
    Aher, Sainath
    Zhu, Jinhua
    Bhagat, Pundlik
    Borse, Laxmikant
    Liu, Xiuhua
    TOPICS IN CURRENT CHEMISTRY, 2024, 382 (01)
  • [25] Oxoplatin-Based Pt(IV) Lipoate Complexes and Their Biological Activity
    Liu, Xiao
    Barth, Marie-Christin
    Cseh, Klaudia
    Kowol, Christian R.
    Jakupec, Michael A.
    Keppler, Bernhard K.
    Gibson, Dan
    Weigand, Wolfgang
    CHEMISTRY & BIODIVERSITY, 2022, 19 (10)
  • [26] Pt(IV) Complexes in the Search for Novel Platinum Prodrugs with Promising Activity
    Sainath Aher
    Jinhua Zhu
    Pundlik Bhagat
    Laxmikant Borse
    Xiuhua Liu
    Topics in Current Chemistry, 2024, 382
  • [27] SYNTHESIS AND ANTITUMOR-ACTIVITY OF RIBOFLAVIN AND FLAVIN MONONUCLEOTIDE PT(II) COMPLEXES
    SUZUKI, K
    NOJI, M
    TASHIRO, T
    KIDANI, Y
    CHEMICAL & PHARMACEUTICAL BULLETIN, 1988, 36 (05) : 1895 - 1898
  • [28] Antitumor activity in vitro of new Pt (II) complexes with cyclic organic ligands
    Karaivanova, M
    Konstantinov, S
    Bakalova, A
    Tcholakova, I
    ANNALS OF ONCOLOGY, 1998, 9 : 33 - 33
  • [29] ANTITUMOR-ACTIVITY OF PT(II) COMPLEXES CONTAINING DIAMINOCARBOXYLATES AND THEIR ESTER DERIVATIVES
    NOJI, M
    HANAMURA, S
    SUZUKI, K
    TASHIRO, T
    KIDANI, Y
    CHEMICAL & PHARMACEUTICAL BULLETIN, 1986, 34 (06) : 2487 - 2493
  • [30] ANTITUMOR ACTIVITIES OF 1,2-CYCLOHEXANEDIAMINE AND 2-(AMINOMETHYL)CYCLOHEXYLAMINE PT(IV) COMPLEXES
    NOJI, M
    SUMI, M
    OHMORI, Y
    KIDANI, Y
    JOURNAL OF PHARMACOBIO-DYNAMICS, 1987, 10 (01): : S1 - S1
12345